Lab tests could pick the right drug for tough myeloma cases

This study tests a new way to choose treatments for people with multiple myeloma or plasma cell leukemia that has returned or stopped responding to standard therapy. Researchers use a lab test that checks many drugs at once, along with genetic information, to find which drug or drug combination might work best for each person. The goal is to see if this personalized approach is practical and can improve treatment choices for 40 participants.